New research adds to calls for better support for long COVID patients
Canada.com
“The question with the neuro-cognitive impacts of COVID-19 are “whether these will resolve some time in the future.” Evans of the Montreal Neurological Institute, meanwhile, said the long-term impact of serious brain impairment after …”
TAGS: COVID-19, pandemic, neuro-cognitive impacts, long-hauler, The Neuro
New study to monitor COVID-19 illness and vaccine safety, effectiveness in children and youth in Canada
BCCHR
“A pan-Canadian study that’s monitoring the effects of COVID-19 and the safety and efficacy of COVID-19 vaccines in Canadian children and adolescents started June 1. The Government of Canada is supporting the study through its COVID-19 Immunity Task Force and Vaccine Surveillance Reference Group.”
TAGS: COVID-19, pandemic, vaccine, innovative research, Provincial Health Services Authority
ImPaKT team expands COVID-19 research to target variants of concern
Western News
“Stephen Barr, associate professor at Schulich Medicine & Dentistry, is one of five Deputies in Pillar 2 of the Network, which looks specifically at …”
TAGS: COVID-19, variants of concern, infectious disease, Western University
Gilead’s remdesivir reduces COVID-19 mortality risk- data
Financial Post
“Gilead Sciences Inc said an analysis showed its antiviral remdesivir reduced mortality rates in hospitalized patients with COVID-19 and increased the …”
TAGS: COVID-19, treatment, remdesivir, antiviral, Gilead Sciences Inc.
New study to assess COVID-19 vaccine effectiveness among people living with HIV
UBC Faculty of Medicine
“The study is further supported by the Canadian Institutes of Health Research (CIHR), the CIHR Canadian HIV Trials Network (CTN) and Stop the …”
TAGS: COVID-19, pandemic, HIV, vaccine
Gilead to Present More Than 70 Abstracts From Diverse Liver Disease Programs At The …
Stockhouse
“The breadth of data reflects Gilead’s continued commitment to liver disease, including the recent expansion into chronic hepatitis delta virus (HDV), with …”
TAGS: innovative research, liver disease, HDV, Gilead Sciences Inc.